57677-52-8

Basic information

• Product Name: TETRADECANOIC ACID-1-13C
• Synonyms: MYRISTIC-1-13C ACID;MYRISTIC ACID (1-13C);TETRADECANOIC ACID-1-13C;MYRISTIC-1-13C ACID, 99 ATOM % 13C;MYRISTIC ACID-1-13C (TETRADECANOIC ACID;Tetradecanoic Acid-13C
• CAS NO: 57677-52-8
• Molecular Formula: C14H28O2
• Molecular Weight: 229.38
• Mol File: 57677-52-8.mol
• Article Data: 0

Chemical Properties

• Melting Point: 52-54 °C(lit.)
• Boiling Point: 250 °C100 mm Hg(lit.)
• Flash Point: >230 °F(lit.)
• Appearance: /
• Density: 0.898g/cm³
• Refractive Index: 1.451
• CAS DataBase Reference: TETRADECANOIC ACID-1-13C(CAS DataBase Reference)
• NIST Chemistry Reference: TETRADECANOIC ACID-1-13C(57677-52-8)
• EPA Substance Registry System: TETRADECANOIC ACID-1-13C(57677-52-8)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 57677-52-8(Hazardous Substances Data)

Usage

Description

TETRADECANOIC ACID-1-13C, also known as Myristic acid-13C, is a 14-carbon saturated fatty acid labeled with a stable carbon isotope (13C). This labeled compound is primarily used as an internal standard for the quantification of myristic acid through gas chromatography (GC) or liquid chromatography-mass spectrometry (LC-MS) techniques. The incorporation of 13C allows for accurate measurement and differentiation from the naturally occurring myristic acid, which is essential in various research and analytical applications.

Uses

Used in Research and Analytical Chemistry:
TETRADECANOIC ACID-1-13C is used as an internal standard for the quantification of myristic acid in GC or LC-MS analyses. The presence of the 13C isotope enables accurate measurement and differentiation from naturally occurring myristic acid, ensuring precise quantification and reliable results in various research and analytical applications.
Used in Pharmaceutical and Biomedical Applications:
TETRADECANOIC ACID-1-13C can be used as a research tool in the study of myristoyl coenzyme A (myristoyl-CoA) and its role in the transfer of myristic acid to the N-terminal glycine of certain proteins. This process is crucial for modifying protein activity during translation or post-translationally in apoptotic cells. Understanding these mechanisms can provide insights into various biological processes and potential therapeutic targets.
Used in Drug Development and Delivery:
As a stable isotope-labeled compound, TETRADECANOIC ACID-1-13C can be employed in the development and optimization of drug delivery systems. Its unique properties may allow for improved targeting, bioavailability, and therapeutic outcomes in various applications, including the development of novel drug carriers and targeted drug delivery systems.

InChI:InChI=1/C14H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h2-13H2,1H3,(H,15,16)/i14+1